A critical advance in cancer investigation is arising with the use of VHH fragments to re-engage mutated p53. This vital cancer inhibitor protein is frequently lost in various forms of tumors, resulting uncontrolled https://sociallweb.com/story7517444/mini-antibodies-reactivate-the-p53-protein-new-new-hope-for-malignant-therapy